Mannose phosphate isomerase deficiency‐congenital disorder of glycosylation (MPI‐CDG) with cerebral venous sinus thrombosis as first and only presenting symptom: A rare but treatable cause of thrombophilia
Abstract Mannose phosphate isomerase deficiency‐congenital disorder of glycosylation (MPI‐CDG; formerly named CDG type 1b) is characterized by the clinical triad of hepatopathy, protein‐losing enteropathy, and hyperinsulinemic hypoglycemia in combination with coagulation disorder (thrombophilia, dep...
Main Authors: | Chris Mühlhausen, Lisa Henneke, Lars Schlotawa, Daniel Behme, Marianne Grüneberg, Jutta Gärtner, Thorsten Marquardt |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | JIMD Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/jmd2.12149 |
Similar Items
-
Dietary mannose supplementation in phosphomannomutase 2 deficiency (PMM2-CDG)
by: Roman Taday, et al.
Published: (2020-09-01) -
Unsuccessful intravenous D-mannose treatment in PMM2-CDG
by: Sarah C. Grünert, et al.
Published: (2019-10-01) -
Clinical outcomes in an adult patient with mannose phosphate isomerase-congenital disorder of glycosylation who discontinued mannose therapy
by: Kinza Noman, et al.
Published: (2020-12-01) -
MPI‐CDG from a hepatic perspective: Report of two Egyptian cases and review of literature
by: Tawhida Y. Abdel Ghaffar, et al.
Published: (2020-11-01) -
Spontaneous improvement of carbohydrate-deficient transferrin in PMM2-CDG without mannose observed in CDG natural history study
by: Peter Witters, et al.
Published: (2021-02-01)